Research Topics

Ken Ichi Ogawara

Summary

Affiliation: Okayama University
Country: Japan

Publications

  1. Ogawara K, Kułdo J, Oosterhuis K, Kroesen B, Rots M, Trautwein C, et al. Functional inhibition of NF-kappaB signal transduction in alphavbeta3 integrin expressing endothelial cells by using RGD-PEG-modified adenovirus with a mutant IkappaB gene. Arthritis Res Ther. 2006;8:R32 pubmed
    ....
  2. Shehata T, Kimura T, Higaki K, Ogawara K. In-vivo disposition characteristics of PEG niosome and its interaction with serum proteins. Int J Pharm. 2016;512:322-328 pubmed publisher
    ....
  3. Ogawara K, Fukuoka Y, Yoshizawa Y, Kimura T, Higaki K. Development of Safe and Potent Oil-in-Water Emulsion of Paclitaxel to Treat Peritoneal Dissemination. J Pharm Sci. 2017;106:1143-1148 pubmed publisher
    ..These results indicate that the adequately sustained PTX release would lead to potent in vivo antitumor activity and that PTX-emulsion B would offer an alternative approach to treat peritoneal dissemination. ..

Detail Information

Publications3

  1. Ogawara K, Kułdo J, Oosterhuis K, Kroesen B, Rots M, Trautwein C, et al. Functional inhibition of NF-kappaB signal transduction in alphavbeta3 integrin expressing endothelial cells by using RGD-PEG-modified adenovirus with a mutant IkappaB gene. Arthritis Res Ther. 2006;8:R32 pubmed
    ....
  2. Shehata T, Kimura T, Higaki K, Ogawara K. In-vivo disposition characteristics of PEG niosome and its interaction with serum proteins. Int J Pharm. 2016;512:322-328 pubmed publisher
    ....
  3. Ogawara K, Fukuoka Y, Yoshizawa Y, Kimura T, Higaki K. Development of Safe and Potent Oil-in-Water Emulsion of Paclitaxel to Treat Peritoneal Dissemination. J Pharm Sci. 2017;106:1143-1148 pubmed publisher
    ..These results indicate that the adequately sustained PTX release would lead to potent in vivo antitumor activity and that PTX-emulsion B would offer an alternative approach to treat peritoneal dissemination. ..